Aflibercept Biosimilar - Research Grade
Bulk Aflibercept Biosimilar - Research Grade
Product Benefits:
ichorbio's Aflibercept Biosimilar - Research Grade is manufactured in a cGMP compliant facility. Our aflibercept biosimilar is for research use only (RUO).
Size:
ichorbio's research grade aflibercept biosimilar is available in the following sizes: 1mg, 5mg, 20mg and 100mg . ichorbio regularly manufactures bulk multi-gram amounts of our aflibercept biosimilar - please contact us for pricing.
Target:
VEGF
Clone:
n/a
Isotype:
IgG1
Other Names:
Vascular Endothelial Growth Factor
Host:
Humanized
Species Reactivity:
Human
Specificity:
Detects human VEGF.
Purification Method:
This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Background:
Aflibercept biosimilar is a recombinant fusion protein consisting of portions of human VEGF receptors 1 and 2 extracellular domains fused to the Fc portion of human IgG1 formulated as an iso-osmotic solution for intravitreal administration. Aflibercept biosimilar is a dimeric glycoprotein with a protein molecular weight of 97 kilodaltons (kDa) and contains glycosylation, constituting an additional 15% of the total molecular mass, resulting in a total molecular weight of 115 kDa. Aflibercept biosimilar is produced in recombinant Chinese hamster ovary (CHO) cells.
Concentration:
1.0 - 5.0 mg/ml
Formulation:
Preservative-free, sterile, aqueous solution. Diluted in 10 mM sodium phosphate, 40 mM sodium chloride, 0.03% polysorbate 20, and 5% sucrose, pH 6.2. BSA and Azide free.
Purity:
>95% by SDS-PAGE and HPLC
Endotoxin:
≤ 0.75 EU/mg as determined by the LAL method
Storage:
Aflibercept Biosimilar - Research Grade is stable for at least four (4) weeks when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –80°C. Avoid Repeated Freeze Thaw Cycles.
Applications:
Functional Assays
Application Notes:
Each investigator should determine their own optimal working dilution for specific applications.
Use: ichorbio's aflibercept biosimilar is for research use only (RUO). Isotype Control:
| Concentration | 9.73mg/ml |
|---|---|
| Isotype | IgG1 |
| Host | Humanized |
| Use | Products are for research use only. Not for use in diagnostic or therapeutic procedures. |
| Storage | Stable for at least one week when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at ï؟½80°C. Avoid Repeated Freeze Thaw Cycles. |
| Endotoxin | ≤ 1.0 EU/mg as determined by the LAL method |
| Purity | >95% by SDS-PAGE and HPLC |
| Formulation | Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free. |
| Purification Method | This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype. |
| Specificity | Detects human VEGF. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Aflibercept. |
| Species Reactivity | Human |
| Target | VEGF |
| Shipping Conditions | Blue ice |
| background | Aflibercept biosimilar is a recombinant fusion protein consisting of portions of human VEGF receptors 1 and 2 extracellular domains fused to the Fc portion of human IgG1 formulated as an iso-osmotic solution for intravitreal administration. Aflibercept bi |
| Other names | Vascular endothelial growth factor |
| UniProt | P15692 |
| Buffer | ICH3001-100ml ICH3002-100ml ICH3003-100ml |
| Sequence | https://www.imgt.org/mAb-DB/ |